Abstract:Acute kidney injury (AKI) is common in hospital patients. Delayed diagnosis and treatment of AKI due to the lack of efficient early diagnosis is an important cause of its high mortality. While fluorescence imaging seems promising to non-intrusively interrogate AKI-related biomarkers, the low kidney contrast of many fluorophores conferred by their relatively low abundance of distribution in the kidney limits their application for AKI detection. Herein, we discovered a near-infrared fluorophore with inherent kidney-targeting ability. Based on this fluorophore, a fluorogenic probe (KNP-1) was developed by targeting peroxynitrite (ONOO−), which is upregulated at the early onset of AKI. KNP-1 exhibits desirable kidney distribution after intravenous administration and is fluorescent only after activation by ONOO−. These properties lead to excellent kidney contrast imaging results. KNP-1 is capable of detecting both nephrotoxin-induced and ischemia-reperfusion injury-induced AKI in live mice. Temporally resolved imaging of AKI-disease model mice with KNP-1 suggests a gradual increase in renal ONOO− levels with disease progression. Notably, the upregulation of ONOO− can be observed at least 24 h earlier than the clinically popular sCr and BUN methods. Blocking ONOO− generation also proves beneficial. These results highlight the applicability of this inherently tissue targeting-based strategy for designing probes with desirable imaging contrast; potentiate ONOO− as a biomarker and target for AKI early diagnosis and medical intervention; and imply the clinical relevance of KNP-1 for AKI early detection.

Recent Advances on Fluorescent Tracers for in Vivo Real-time Monitoring Glomerular Filtration Rate

Recent Advances in Engineered Nanomaterials for Acute Kidney Injury Theranostics

Fluorimetric Tool to Discriminate Glomerular and Tubular Injuries In Vivo

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

Recent Progress in Molecular Probes for Imaging of Acute Kidney Injury

Probing the viscosity changes of acute kidney injury by fluorescence imaging

Redox-Reversible Near-Infrared Fluorescent Probe for Imaging of Acute Kidney Oxidative Injury and Remedy

Biomarkers for Early Diagnosis of Acute Kidney Injury: Current Progress and Clinical prospects.

Construction of a sequence activated fluorescence probe for simultaneous detection of γ-glutamyl transpeptidase and peroxynitrite in acute kidney injury

Fluoro‐Photoacoustic Polymeric Renal Reporter for Real‐Time Dual Imaging of Acute Kidney Injury

Optical Molecular Probes for Imaging and Early Diagnosis of Acute Kidney Injury

Non-small Nanoprobes Based on FDA-approval Formulation for NIR-II Imaging and Detection of Drug-induced Acute Kidney Injury

Near-Infrared Fluorescence Probes for Monitoring and Diagnosing Nephron-Urological Diseases

High‐contrast Noninvasive Imaging of Kidney Clearance Kinetics Enabled by Renal Clearable Nanofluorophores

An Activatable Near-Infrared Fluorescence Probe for in Vivo Imaging of Acute Kidney Injury by Targeting Phosphatidylserine and Caspase-3

Rapid and non-invasive renal injury diagnosis unlocked by a glimpse into urinary protein particle size and charge

Recent advances of photoresponsive nanomaterials for diagnosis and treatment of acute kidney injury

Super-resolution ultrasound imaging for in vivo microvasculature assessment in acute kidney injury mouse model

Functional Magnetic Resonance Imaging in Acute Kidney Injury: Present Status

Noninvasive Staging of Kidney Dysfunction Enabled by Renal-Clearable Luminescent Gold Nanoparticles

Methods for Assessment of the Glomerular Filtration Rate in Laboratory Animals.